Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

Share Price is delayed by 15 minutes
Get Live Data
72.40    -0.80 (-1.09%)
Bid:
71.10
Ask:
72.40
Spread: 1.30 (1.828%)
Market Cap: £395.00m
FSFL Live PriceLast checked at - London Stock Exchange

Intraday Foresight Solar Fund Share Chart

Autumn Statement - Electricity Generator Levy

24 Nov 2022 07:00

RNS Number : 4244H
Foresight Solar Fund Limited
24 November 2022
 

24 November 2022

 

Foresight Solar Fund Limited ("Foresight Solar" or the "Company")

 

Autumn Statement Update - Electricity Generator Levy

 

Foresight Solar Fund Limited, a fund investing in a diversified portfolio of ground-based solar PV and battery storage assets in the UK and internationally, announces the potential impact of the Electricity Generator Levy relative to the Company's unaudited NAV as of 30 September 2022 (£771.2 million, 126.4 pence per share).

 

On 17 November 2022 the Chancellor of the Exchequer announced, as part of the Autumn Statement, the introduction of a new Levy on excess profits realised by UK electricity generators, the Electricity Generator Levy. The Levy is proposed to take effect for the period from 1 January 2023 until 31 March 2028 at a rate of 45% of Exceptional Generation Receipts, which are calculated as revenue from power sales above a benchmark price of £75/MWh. A £10 million per year allowance will apply, such that Exceptional Generation Receipts below this threshold will be exempt.

 

The Company's UK solar assets are expected to fall within the scope of the proposed Levy. The Company's UK battery storage assets are not expected to fall within the scope of the proposed Levy. In respect of the UK solar assets which are within scope, revenues earned under Feed in Tariffs ('FiT'), Renewable Obligation Certificates ('ROCs') or Contracts for Differences ('CfDs') will be exempt from the proposed Levy.

 

The Directors have reviewed the details of the proposed Electricity Generator Levy and assessed the potential impact the Levy (ignoring any other potential adjustments) would have on the Company's 30 September 2022 NAV.

 

The Company's NAV calculated as of 30 September 2022 incorporated discounts applied to the blended Q3 2022 power curves for the period FY 2023 to FY 2027 inclusive, reflective of the uncertainty surrounding the likely form of Government intervention in the UK energy markets. In assessing the potential net impact of the Electricity Generator Levy on the 30 September NAV, the Company has:

 

1)

Reversed the power curve discounts applied to the periods FY2023-FY2027 (increasing the September NAV by 7.8 pence per share); and,

2)

Applied the proposed Levy on forecast UK solar generation revenues (reducing the September NAV by 8.6 pence per share).

 

The net impact of these changes alone would be to reduce the 30 September 2022 NAV by 0.8 pence per share.

 

The Autumn Statement provides greater clarity as to the Government's approach to energy policy with regards to UK renewable electricity generators. The Government has announced its intention to publicise draft legislation for the proposed Electricity Generator Levy in mid-December 2022. The Company will reflect the expected impact of the Levy (along with any other appropriate adjustments) in the 31 December 2022 NAV update.

 

 

 

For further information, please contact:

Foresight Group

Sophie Sutherland

(InstitutionalIR@ForesightGroup.eu)

Jefferies International Limited

+44(0)20 7029 8000

Neil Winward

Gaudi Le Roux

Citigate Dewe Rogerson

+44(0)20 7638 9571

Toby Moore

Lucy Gibbs

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBXLLLLFLZFBQ
Date   Source Headline
24th Nov 20207:00 amRNSListing pursuant to Scrip Alternative and TVR
13th Nov 20204:34 pmRNSDirector Shareholding
13th Nov 20207:00 amRNSQ3 2020 Net Asset Value and Operational Update
6th Nov 20209:12 amRNSScrip Share Price
4th Nov 20203:14 pmRNSHolding(s) in Company
7th Oct 20209:25 amRNSHolding(s) in Company
11th Sep 20202:43 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSAcquisition of First Spanish Solar Asset
3rd Sep 20207:00 amRNSInterim Results to 30 June 2020
2nd Sep 20203:00 pmRNSDirector/PDMR Shareholding
26th Aug 202012:07 pmRNSAdditional listing pursuant to Scrip Alternative
25th Aug 20203:41 pmRNSAppointment of Non-Executive Director
21st Aug 20201:46 pmRNSHolding(s) in Company
6th Aug 20202:39 pmRNSScrip Share Price
4th Aug 20207:00 amRNSNotice of Results
22nd Jul 20207:00 amRNSDeclaration of Dividend
16th Jul 20204:24 pmRNSResult of 2020 Annual General Meeting
8th Jul 20203:13 pmRNSDirector Shareholding
23rd Jun 20207:00 amRNSNotice of 2020 Annual General Meeting
1st Jun 202011:04 amRNSTotal Voting Rights
26th May 20204:04 pmRNSAdditional listing pursuant to Scrip Alternative
11th May 20202:33 pmRNSScrip Share Price
4th May 20207:00 amRNSQ1 2020 Net Asset Value and Operational Update
27th Mar 20207:00 amRNSCOVID-19 Update
26th Mar 20207:00 amRNSAppointment of Corporate Broker
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSAnnual Results to 31 December 2019
27th Feb 20207:00 amRNSAdditional listing pursuant to Scrip Alternative
26th Feb 20207:00 amRNSRestructuring of Investment Management Arrangement
19th Feb 20207:00 amRNSQ4 2019 Net Asset Value
6th Feb 20201:59 pmRNSScrip Share Price
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 202012:08 pmRNSCORRECTION: Dividend Declaration
22nd Jan 20204:21 pmRNSDividend Declaration
29th Nov 20196:09 pmRNSTotal Voting Rights
28th Nov 20199:36 amRNSOFGEM 'Targeted Charging Review' Update
28th Nov 20199:33 amRNSAdditional Scrip Listing and Total Voting Rights
14th Nov 20192:27 pmRNSDirector Declaration
11th Nov 20197:00 amRNSQ3 2019 Net Asset Value
31st Oct 20192:46 pmRNSScrip Share Price and Total Voting Rights
17th Oct 20195:00 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSResult of Placing and Total Voting Rights
1st Oct 20197:00 amRNSProposed Placing of Ordinary Shares and NAV
25th Sep 20199:25 amRNSHolding(s) in Company
3rd Sep 20194:10 pmRNSHolding(s) in Company
29th Aug 201911:51 amRNSAdditional Listing - Scrip Alternative and TVR
22nd Aug 20197:00 amRNSInterim Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.